BioAtla (BCAB) Total Liabilities (2020 - 2026)

BioAtla's Total Liabilities history runs 7 years deep, the most recent figure standing at $45.9 million for Q1 2026.

• On a quarterly basis, Total Liabilities rose 21.55% year-over-year to $45.9 million in Q1 2026; TTM through Mar 2026 was $45.9 million, a 21.55% increase from a year earlier, with the FY2025 full-year figure at $50.0 million, up 31.08% from the prior year.
• Total Liabilities retreated to $45.9 million in Q1 2026 per BCAB's latest filing, from $50.0 million in the prior quarter.
• Across five years, Total Liabilities topped out at $56.7 million in Q3 2023 and bottomed at $37.3 million in Q2 2024.
• The 5-year median for Total Liabilities is $45.9 million (2026), against an average of $45.2 million.
• Across the five-year window, Total Liabilities slumped 32.39% in 2024 and jumped 31.08% in 2025, its largest moves.
• Year by year, Total Liabilities stood at $45.4 million in 2022, then climbed by 7.91% to $49.0 million in 2023, then dropped by 22.11% to $38.2 million in 2024, then jumped by 31.08% to $50.0 million in 2025, then declined by 8.28% to $45.9 million in 2026.
• Per Business Quant, the three latest BCAB Total Liabilities figures stand at $45.9 million (Q1 2026), $50.0 million (Q4 2025), and $47.1 million (Q3 2025).